Ultime notizie per Vestis (NYSE:VSTS) Azioni

Vestis

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

Vestis Corp

WIIM

PLAY

Dave & Buster's Entertainment shares are trading higher. The company reported Q4 financial results.

LUNR

Intuitive Machines shares are trading higher after the company announced it selected SpaceX's Falcon 9 rocket to launch its IM-4 mission.

Piper Sandler analyst Patrick Moley maintains Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) with a Overweight and raises the price target from $230 to $234.

News

Price Target

Analyst Ratings

CBOE

Piper Sandler Maintains Overweight on Cboe Global Markets, Raises Price Target to $234

<a href="https://www.globenewswire.com/Tracker?data=anjZZ5NFe4HHTtrbpd07U7msN3R5-feH9COEjLdHIiVAYwP8Ltg3EP6R2EXUMuv8flf-XtV8xXUO4dDUiDGfpaO9kRDiXi_bQ4PSy7M6BXs=">NewtekOne, Inc.</a> (the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) is pleased to provide the following preliminary loan and deposit metrics for its first quarter ending March 31, 2025:
<ul>
<li>SBA 7(a) loans. In 1Q25, the Company originated 580 SBA 7(a) loans totaling $213 million, which compares to 1Q24 SBA 7(a) originations of 489 totaling $212 million. SBA 7(a) loans held for investment ("HFI") within Newtek Bank, N.A. ("Newtek Bank") stood at roughly $407 million as of March 31, up 7% from December 31, 2024 and 90% from March 31, 2024. NewtekOne continues to project SBA 7(a) originations for 2025 at $1 billion.</li>
<li>Commercial Real Estate ("CRE") and Commercial &amp; Industrial ("C&amp;I") loans. Newtek Bank originated $41 million and $23 million of CRE and C&amp;I loans HFI in 1Q25. Newtek Bank's CRE and C&amp;I loans HFI portfolio totaled $231 million and $51 million, respectively, at March 31. Q/Q growth in the CRE portfolio was particularly strong at 20% while sequential net growth in the C&amp;I portfolio of 7% included $20 million of C&amp;I loans sold during Q1. Expected 2025 growth of $225 million in CRE and C&amp;I balances implies a year-end combined CRE/C&amp;I portfolio at Newtek Bank of roughly $464 million, or 94% Y/Y growth. We believe that growth of the CRE and C&amp;I portfolio adds diversification to Newtek Bank's total loan portfolio and reduces risks with different borrower profiles and with loans underwritten in higher interest and cap rate environments.</li>
<li>SBA 504 loans. In 1Q25, the Company's non-bank subsidiary and Newtek Bank originated $17 million of SBA 504 loans and executed $13 million of SBA 504 loan sales. The Company continues to anticipate $250 million of SBA 504 loan originations in 2025.</li>
<li>Alternative Loan Program ("ALP") loans. The Company originated $68.5 million of ALP loans in 1Q25 and continues to estimate $500 million of ALP originations in 2025. ALP loans are held on the Company's balance sheet and in its two joint ventures.</li>
<li>Deposits. Newtek Bank ended 1Q25 with approximately $1.06 billion1 of deposits, a sequential increase of 2% over 4Q24 and year-over-year increase of 88%. On a Q/Q basis, business deposits increased 8.9%, core consumer deposit balances grew 2.5%, and wholesale deposits declined 32%. The Company continues to project Newtek Bank's deposits to grow by $245 million in 2025. &nbsp;</li>
</ul>
Barry Sloane, CEO, President and Chairman, said, "As loan and deposit volumes are tracking at or above projections, we remain comfortable with 2025 EPS guidance of $2.10-$2.50 per share. We continue to find comfort in the above-average profitability our operating model generates, which we believe is particularly pertinent in times of elevated volatility similar to what the broader market is experiencing now. We look forward to sharing 1Q25 results with the investment community on May 6."

Guidance

NEWT

NewtekOne Reaffirms 2025 EPS Guidance Of $2.10-$2.50 Per Share

Piper Sandler analyst Patrick Moley maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $275 to $283.

Piper Sandler Maintains Overweight on CME Group, Raises Price Target to $283

ECARX Holdings shares are trading higher after the company announced it increased its share repurchase program by $20 million to $40 million.

TRNR

Interactive Strength shares are trading higher after the company signed a binding agreement to acquire Wattbike.

RCI Hospitality Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RICK#NASDAQ">RICK</a>) reported club and restaurant sales for the fiscal second quarter ended March 31, 2025. Sales do not include non-core operations and are subject to final closing. Full 2Q25 financial results are expected to be reported by May 12, 2025.
Eric Langan, President &amp; CEO of RCI, commented: "Due to bad weather in January and February, 18 clubs and Bombshells had to close 1 or 2 days each. Even if they were able to open, a number of those and other locations experienced slower business, particularly on weekends when temperatures were below zero or had heavy snow and ice, for example, in Dallas and Houston. Then sales began to improve in March with warmer temperatures."
"The quarter also included the acquisition of Flight Club in Detroit and the opening of Bombshells Denver, both in late January, and the opening of Chicas Locas El Paso in March. Year over year, most of the second quarter's sales decline was due to the previously announced divestiture and closure of underperforming Bombshells locations."
Club &amp; Restaurant Sales ($ in Millions)
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">2Q25</td>
<td colspan="1" rowspan="1">Total Sales</td>
<td colspan="1" rowspan="1">Total Sales vs. 2Q24</td>
<td colspan="1" rowspan="1">Same-Store Sales vs. 2Q24</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Nightclubs</td>
<td colspan="1" rowspan="1">$57.1</td>
<td colspan="1" rowspan="1">-3.1%</td>
<td colspan="1" rowspan="1">-3.5%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bombshells</td>
<td colspan="1" rowspan="1">$8.2</td>
<td colspan="1" rowspan="1">-35.6%</td>
<td colspan="1" rowspan="1">-13.4%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Combined</td>
<td colspan="1" rowspan="1">$65.4</td>
<td colspan="1" rowspan="1">-8.9%</td>
<td colspan="1" rowspan="1">-4.7%</td>
</tr>
</tbody>
</table>
</figure>

Earnings

RICK

RCI Reports Q2 2025 Club & Restaurant Sales With Combined Revenue Of $65.4M

ADPT

Adaptive Biotechnologies shares are trading higher after the company announced that Palmetto GBA expanded its coverage of cloneSEQ.

Piper Sandler analyst Patrick Moley maintains BGC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGC#NASDAQ">BGC</a>) with a Overweight and raises the price target from $12 to $14.

Piper Sandler Maintains Overweight on BGC Group, Raises Price Target to $14

Piper Sandler analyst Nicole Miller Regan maintains Dave &amp; Buster's Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) with a Neutral and lowers the price target from $33 to $22.

Piper Sandler Maintains Neutral on Dave & Buster's Enter, Lowers Price Target to $22

<ul>
<li>Janus Henderson will manage the $45 billion investment grade public fixed income asset portfolio for Guardian's general account, becoming Guardian's investment grade public fixed income asset manager</li>
<li>Guardian will receive equity warrants and other economic consideration, supporting a shared goal of accelerating growth and creating value</li>
<li>Guardian will commit up to $400 million of seed capital for Janus Henderson fixed income product innovation</li>
<li>Guardian and Janus Henderson will also co-develop proprietary, multi-asset solution model portfolios for Guardian's dually registered broker-dealer and registered investment advisor, Park Avenue Securities (PAS)</li>
</ul>
The Guardian Life Insurance Company of America&#xAE; ("Guardian"), one of America's largest life insurers and a leading provider of employee benefits, and Janus Henderson Group plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>, "Janus Henderson"))), a leading global asset manager, today announced an innovative strategic partnership, whereby Janus Henderson will become Guardian's investment grade public fixed income asset manager. Through the partnership, Janus Henderson will manage the $45 billion investment grade public fixed income portfolio for Guardian's general account, which will include investment grade corporates and securitized credit. As part of the agreement, Guardian investment professionals currently supporting the in-scope asset classes will have the opportunity to join Janus Henderson, providing continuity in the management of these assets while further enhancing Janus Henderson's specialized insurance investment capabilities.

Janus Henderson Group plc Ordinary Shares

Janus Henderson And Guardian Life Insurance Announce Strategic Partnership, With Janus Henderson Managing Guardian's Investment Grade Public Fixed Income Portfolio, Committing To $400M In Seed Capital For Fixed Income Innovation, And Co-Developing Multi-Asset Solutions

NextDecade shares are trading higher after the company announced a 20-year LNG sale and purchase agreement to supply 1.2 million tonnes per year to a subsidiary of Saudi Aramco.

Piper Sandler analyst Crispin Love maintains Virtus Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NYSE">VRTS</a>) with a Overweight and lowers the price target from $252 to $216.

VRTS

Piper Sandler Maintains Overweight on Virtus Inv, Lowers Price Target to $216

BREA

Italian Football Federation Completed Review Of Brera Holdings' Acquisition Of Stake In S.S. Juve Stabia

Barclays analyst Matthew Bouley maintains Builders FirstSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) with a Overweight and lowers the price target from $165 to $151.

BLDR

Barclays Maintains Overweight on Builders FirstSource, Lowers Price Target to $151

PCRX

Pacira BioSciences shares are trading higher after HC Wainwright & Co. raised its price target on the stock from $48 to $65 and maintained a Buy rating.

CRMD

CorMedix shares are trading higher after the company issued Q1 preliminary revenue guidance above estimates.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Oppenheimer cut Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) price target from $350 to $300. Oppenheimer analyst Ken Wong maintained an Outperform rating. Autodesk shares closed at $243.62 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/ADSK/analyst-ratings">view this stock</a>.</li>
<li>B of A Securities slashed the price target for Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) from $75 to $70. B of A Securities analyst Robert Ohmes maintained an Underperform rating. Dollar Tree shares closed at $72.84 on Monday. <a href="https://www.benzinga.com/quote/DLTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird lowered Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) price target from $105 to $80. Baird analyst David Koning maintained an Outperform rating. Block shares closed at $50.47 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/XYZ/analyst-ratings">view this stock</a>.</li>
<li>Wells Fargo cut the price target for Ralph Lauren Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) from $275 to $240. Wells Fargo analyst Ike Boruchow upgraded the stock from Equal-Weight to Overweight. Ralph Lauren shares closed at $193.17 on Monday. <a href="https://www.benzinga.com/quote/RL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup cut the price target for Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from $53 to $48. Citigroup analyst Ariel Rosa upgraded the stock from Neutral to Buy. Knight-Swift Transportation shares closed at $39.30 on Monday. <a href="https://www.benzinga.com/quote/KNX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised Rocket Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) price target from $10 to $14. Barclays analyst Terry Ma upgraded the stock from Underweight to Equal-Weight. Rocket Companies shares settled at $14.66 on Monday. <a href="https://www.benzinga.com/quote/RKT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan cut Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) price target from $19 to $17. JP Morgan analyst Matthew Boss upgraded the stock from Neutral to Overweight. Levi Strauss shares closed at $13.50 on Monday. <a href="https://www.benzinga.com/quote/LEVI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies increased Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) price target from $53 to $64. Jefferies analyst David Windley upgraded the stock from Underperform to Hold. Centene shares closed at $61.35 on Monday.  <a href="https://www.benzinga.com/quote/CNC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised the price target for Rhythm Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) from $81 to $92. Canaccord Genuity analyst Whitney Ijem maintained a Buy rating. Rhythm Pharmaceuticals shares settled at $54.96 on Monday. <a href="https://www.benzinga.com/quote/RYTM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo raised Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) price target from $140 to $150. Wells Fargo analyst Ike Boruchow upgraded the stock from Equal-Weight to Overweight. Ross Stores shares closed at $127.88 on Monday. <a href="https://www.benzinga.com/quote/ROST/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ROST stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="452" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39-1024x452.png" alt="" class="wp-image-861945" style="width:682px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39-1024x452.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39-300x132.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39-768x339.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39.png 1398w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:<a href="https://www.benzinga.com/news/earnings/25/04/44678688/dow-falls-for-3rd-session-amid-trumps-tariff-threats-as-apple-tesla-decline-greed-index-remains-in-extreme-fear-zone"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44678688/dow-falls-for-3rd-session-amid-trumps-tariff-threats-as-apple-tesla-decline-greed-index-remains-in-extreme-fear-zone">Dow Falls For 3rd Session Amid Trump&#8217;s Tariff Threats As Apple, Tesla Decline: Greed Index Remains In &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

ADSK

DLTR

LEVI

ROST

RYTM

Ross Stores To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Tuesday

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.tetratech.com%2F&amp;esheet=54235234&amp;newsitemid=20250407434449&amp;lan=en-US&amp;anchor=Tetra+Tech%2C+Inc.&amp;index=1&amp;md5=8ddc3b3bbd432b1ff04b9c4c5a5b580a">Tetra Tech, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today the Government Services Administration awarded the Company a contract for broad service areas under the One Acquisition Solution for Integrated Services (OASIS+) unrestricted program. OASIS+ is the largest government-wide contract program designed to deliver professional services to federal agencies. The 5-year, multiple-award Indefinite Delivery Indefinite Quantity OASIS+ contract is a Best-in-Class vehicle open to all federal agencies and has an unlimited ceiling value.
Tetra Tech has been selected for multiple technical service areas to meet the diverse needs of federal agencies including management and advisory, research and development, technical and engineering, environmental, facilities, intelligence, and logistics services.

Contracts

TTEK

Tetra Tech Awarded OASIS+ Contract By The Government Services Administration For Broad Service Areas, Enabling Provision Of Management, Engineering, Environmental, And Other Professional Services To Federal Agencies Under Unlimited Ceiling Value Over 5-Years

Press Releases

Vestis Appoints Bill Goetz to the Board of Directors

Vestis Reports Third Quarter 2024 Results

Vestis Announces Quarterly Cash Dividend

Vestis Confirms Receipt of Preliminary Inquiry

Vestis to Sell Minority Stake in Japanese Joint Venture

Vestis Announces Date for Fiscal Fourth Quarter and Full-Year 2024 Earnings Results

Vestis Reports Fourth Quarter and Fiscal 2024 Results

Vestis Announces Date for Fiscal First Quarter 2025 Earnings Results

Vestis Reports First Quarter 2025 Results; Reaffirms FY25 Guidance; Announces Chief Financial Officer and Chief Legal Officer Transitions

Comments

Vestis

Notizie

Ultime notizie per Vestis (NYSE:VSTS) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO